Wentao Tian

849 total citations · 2 hit papers
15 papers, 454 citations indexed

About

Wentao Tian is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Wentao Tian has authored 15 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 10 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Wentao Tian's work include Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Wentao Tian is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Lung Cancer Treatments and Mutations (5 papers) and Lung Cancer Diagnosis and Treatment (4 papers). Wentao Tian collaborates with scholars based in China and United States. Wentao Tian's co-authors include Rongrong Zhou, Xianjing Chu, Ziqi Wang, Guilong Tanzhu, Jiaoyang Ning, Jing Zhang, Gang Xiao, Fang Wu, Chenghui Cao and Long Shu and has published in prestigious journals such as JNCI Journal of the National Cancer Institute, Scientific Reports and Frontiers in Immunology.

In The Last Decade

Wentao Tian

14 papers receiving 449 citations

Hit Papers

Cancer stem cells: advanc... 2023 2026 2024 2024 2023 50 100 150
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Cancer stem cells: advances in knowledge and implications for cancer therapy
    2024 191 citations Xianjing Chu, Wentao Tian et al. Signal Transduction and Targeted Therapy profile →
  2. Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials
    2023 114 citations Xianjing Chu, Wentao Tian et al. Molecular Cancer profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wentao Tian China 7 226 155 98 95 78 15 454
Tomás G. Lyons United States 10 219 1.0× 219 1.4× 60 0.6× 106 1.1× 96 1.2× 18 442
Shanbao Li China 10 207 0.9× 261 1.7× 80 0.8× 83 0.9× 177 2.3× 19 526
Shangce Du China 13 144 0.6× 222 1.4× 95 1.0× 106 1.1× 140 1.8× 14 469
Jin-Zhi Xu China 9 225 1.0× 205 1.3× 70 0.7× 72 0.8× 152 1.9× 10 426
Peifen Fu China 9 214 0.9× 135 0.9× 93 0.9× 45 0.5× 97 1.2× 19 390
Elena Tutunea-Fatan Canada 9 176 0.8× 185 1.2× 83 0.8× 30 0.3× 73 0.9× 15 387
Simone Scagnoli Italy 12 293 1.3× 109 0.7× 121 1.2× 142 1.5× 83 1.1× 41 464
Pei-Qi Huang China 12 120 0.5× 195 1.3× 119 1.2× 62 0.7× 124 1.6× 22 432
Kaimi Li China 12 138 0.6× 211 1.4× 79 0.8× 102 1.1× 132 1.7× 15 397
Shaoyong Peng China 13 159 0.7× 193 1.2× 57 0.6× 64 0.7× 161 2.1× 24 437

Countries citing papers authored by Wentao Tian

Since Specialization
Citations

This map shows the geographic impact of Wentao Tian's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wentao Tian with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wentao Tian more than expected).

Fields of papers citing papers by Wentao Tian

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wentao Tian. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wentao Tian. The network helps show where Wentao Tian may publish in the future.

Co-authorship network of co-authors of Wentao Tian

This figure shows the co-authorship network connecting the top 25 collaborators of Wentao Tian. A scholar is included among the top collaborators of Wentao Tian based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wentao Tian. Wentao Tian is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
2.
Zhang, Yingzhe, et al.. (2025). Tumor-educated cells in tumor microenvironment: Key drivers of immunotherapy resistance. Chinese Journal of Cancer Research. 37(3). 446–465. 1 indexed citations
3.
Ning, Jiaoyang, Yu Zeng, Gang Xiao, et al.. (2024). The scheme, and regulative mechanism of pyroptosis, ferroptosis, and necroptosis in radiation injury. International Journal of Biological Sciences. 20(5). 1871–1883. 22 indexed citations
4.
Chu, Xianjing, Wentao Tian, Jiaoyang Ning, & Rongrong Zhou. (2024). Efficacy and safety of personalized optimal PD-(L)1 combinations in advanced NSCLC: a network meta-analysis. JNCI Journal of the National Cancer Institute. 116(10). 1571–1586. 6 indexed citations
5.
Tian, Wentao, Jiaoyang Ning, Yin Shi, et al.. (2024). Cost-effectiveness of tumor-treating fields plus standard therapy for advanced non-small cell lung cancer progressed after platinum-based therapy in the United States. Frontiers in Pharmacology. 15. 1333128–1333128. 4 indexed citations
6.
Chu, Xianjing, Wentao Tian, Jiaoyang Ning, et al.. (2024). Cancer stem cells: advances in knowledge and implications for cancer therapy. Signal Transduction and Targeted Therapy. 9(1). 170–170. 191 indexed citations breakdown →
7.
8.
9.
Wang, Shuxing, Zhuqing Liu, Wentao Tian, et al.. (2023). Efficacy and safety of first-line immune checkpoint inhibitors combined with chemotherapy for extensive-stage small cell lung cancer: A network meta-analysis. Lung Cancer. 178. 47–56. 24 indexed citations
10.
Tian, Wentao, Xianjing Chu, Guilong Tanzhu, & Rongrong Zhou. (2023). Optimal timing and sequence of combining stereotactic radiosurgery with immune checkpoint inhibitors in treating brain metastases: clinical evidence and mechanistic basis. Journal of Translational Medicine. 21(1). 244–244. 11 indexed citations
11.
12.
Chu, Xianjing, Wentao Tian, Ziqi Wang, Jing Zhang, & Rongrong Zhou. (2023). Co-inhibition of TIGIT and PD-1/PD-L1 in Cancer Immunotherapy: Mechanisms and Clinical Trials. Molecular Cancer. 22(1). 93–93. 114 indexed citations breakdown →
13.
Tian, Wentao, Jian Zou, Xiaohan Liu, et al.. (2022). Adjuvant EGFR Tyrosine Kinase Inhibitors for Patients with Resected EGFR -Mutated Non-Small-Cell Lung Cancer: A Network Meta-Analysis. Future Oncology. 18(21). 2695–2707. 2 indexed citations
14.
Tian, Wentao, Yi Liu, Chenghui Cao, et al.. (2021). Chronic Stress: Impacts on Tumor Microenvironment and Implications for Anti-Cancer Treatments. Frontiers in Cell and Developmental Biology. 9. 777018–777018. 40 indexed citations
15.
Tian, Wentao, Chenghui Cao, Long Shu, & Fang Wu. (2020). <p>Anti-Angiogenic Therapy in the Treatment of Non-Small Cell Lung Cancer</p>. OncoTargets and Therapy. Volume 13. 12113–12129. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tomás G. Lyons Breakdown of academic impact, for papers by Shanbao Li Breakdown of academic impact, for papers by Shangce Du Breakdown of academic impact, for papers by Jin-Zhi Xu Breakdown of academic impact, for papers by Peifen Fu Breakdown of academic impact, for papers by Elena Tutunea-Fatan Breakdown of academic impact, for papers by Simone Scagnoli Breakdown of academic impact, for papers by Pei-Qi Huang Breakdown of academic impact, for papers by Kaimi Li Breakdown of academic impact, for papers by Shaoyong Peng
Rankless by CCL
2026